https://www.selleckchem.com/pr....oducts/e7766-diammon
A higher incidence of bilateral primary aldosteronism in women is reported. Treatment of bilateral primary aldosteronism usually involves mineralocorticoid receptor antagonists. However, the impact of **** on renal outcomes is unknown. We compared renal outcomes between the ****es after mineralocorticoid receptor antagonist initiation by analyzing data obtained from 415 female and 313 male patients with bilateral primary aldosteronism who were treated with spironolactone or eplerenone in the JPAS (Japan Primary Aldosteronism
처럼
논평
공유하다
